306
Participants
Start Date
January 23, 2019
Primary Completion Date
May 7, 2021
Study Completion Date
October 22, 2022
HepQuant SHUNT Liver Diagnostic Test
One time testing using the HepQuant SHUNT Liver Diagnostic Test kit (the combination product) in subjects with CLD and undergoing a standard of care EGD. The SHUNT test will be completed prior to the EGD. Each subject will receive an IV push dose of 13C Cholate mixed with Albumin simultaneously with an oral dose of d4 Cholate
Univ of Pennsylvania Hospital, Philadelphia
Digestive Disease Associates, Catonsville
Bon Secours, Richmond, Richmond
Bon Secours, Newport News, Newport News
Gastroenterology Consultants of SW VA, Roanoke
PMG Research, Winston-Salem
Lucas Research (Diabetes & Endocrinology Consultants, PC), Morehead City
Ralph H Johnson Veterans Affairs Medical Center, Charleston
Mayo Clinic, Jacksonville, Jacksonville
Gastroenterology Associates of Pensacola, Pensacola
Accel Research Sites, Orange City
Nature Coast Clinical Research, Inverness
Gastroenterology Health Partners, PLLC, New Albany
Mayo Clinic, Rochester, Rochester
St Louis University, St Louis
Tandem Clinical Research, Marrero
Methodist Dallas Liver Center, Dallas
Baylor, Scott & White, Dallas
Clinical Trials of Texas, San Antonio
Peak Gastroenterlogy Associates, Colorado Springs
Intermountain Healthcare, Murray
Arizona Liver Health, Chandler
California Liver Research Institute, Pasadena
Southern CA Research Center, Coronado
Inland Empire Liver Foundation, Rialto
University of WA, Seattle
Lead Sponsor
HepQuant, LLC
INDUSTRY